AMERICA NEWS NOW
U.S. regulators sped up the support of Pfizer’s COVID-19 vaccine to alteration vaccine mandates, according to newly released emails.
Pfizer and BioNTech asked the U.S. Food and Drug Administration (FDA) successful May 2021 to o.k. their vaccine. Regulators said publically that the reappraisal of the Biologics License Application would apt beryllium done by January 2022, but down the scenes apical bureau officials were pushing the Office of Vaccines Research and Review (O...